Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
Journal
Overview
Identity
View All
Overview
publication venue for
The survival benefit of deceased donor liver transplantation using MELD 3.0: A contemporary analysis. .
32:865-872.
2025
Evaluating the representativeness and validity of Cosmos as a novel, large-scale, real-world data source for liver transplant research.
2025
Management of hepatic artery thrombosis and stenosis after pediatric liver transplantation: Variability and agreement in management practices. .
31:1533-1544.
2025
Characterizing practice variations in the care of hospitalized patients with cirrhosis across the University of California Health. .
32:346-356.
2025
Cannabis and liver transplant in the era of legalization: Effects of pretransplant cannabis use on postoperative opioid use and transplant outcomes. .
31:1398-1410.
2025
Coproducing a health advocate intervention for pediatric liver transplant recipients using a human-centered design. .
31:1143-1153.
2025
Differential aging trends among candidates for liver transplant with and without HCC. .
31:716-726.
2025
Cognitive dysfunction, psychiatric distress, and functional decline after liver transplantation. .
31:1020-1030.
2025
Material economic hardships are associated with adverse 1-year outcomes after pediatric liver transplantation: Prospective cohort results from the multicenter SOCIAL-Tx Study. .
31:1042-1052.
2024
Takotsubo cardiomyopathy following liver transplantation: A multicenter cohort study. .
31:623-629.
2024
The Liver Frailty Index enhances mortality risk prediction above and beyond MELD 3.0 alone. .
30:1326-1329.
2024
Outpatient mean arterial pressure: A potentially modifiable risk for acute kidney injury and death among patients with cirrhosis. .
30:679-688.
2024
Financial burden following adult liver transplantation is common and associated with adverse recipient outcomes. .
30:918-931.
2024
Development and validation of a RE current L iver c A ncer P rediction S cor E (RELAPSE) following liver transplantation in patients with hepatocellular carcinoma: analysis of the us multicenter hcc transplant consortium. .
29:683-697.
2023
Serum and plasma protein biomarkers associated with frailty in patients with cirrhosis. .
29:1089-1099.
2023
CT-quantified sarcopenic visceral obesity is associated with poor transplant waitlist mortality in patients with cirrhosis. .
29:476-484.
2023
Outcomes in liver transplant recipients with nonalcoholic fatty liver disease-related HCC: results from the US multicenter HCC transplant consortium. .
29:34-47.
2022
Multicenter assessment of hypertension management among liver transplantation recipients. .
29:122-124.
2022
Association of serum metabolites and gut microbiota at hospital admission with nosocomial infection development in patients with cirrhosis. .
28:1831-1840.
2022
Novel approaches are needed to study social determinants of health in liver transplantation. .
29:241-243.
2022
Financial burden in adults with chronic liver disease: A scoping review. .
28:1920-1935.
2022
Caregiver perspectives on the everyday medical and social needs of long-term pediatric liver transplant patients. .
28:1735-1746.
2022
A review of racial, socioeconomic, and geographic disparities in pediatric liver transplantation. .
28:1520-1528.
2022
Redefining Success After Liver Transplantation: From Mortality Toward Function and Fulfillment. .
28:304-313.
2021
Integrating Specialist Palliative Care in the Liver Transplantation Evaluation Process: A Qualitative Analysis of Hepatologist and Palliative Care Provider Views. .
28:678-688.
2021
The Prediction of In-Hospital Mortality in Decompensated Cirrhosis with Acute-on-Chronic Liver Failure. .
28:560-570.
2021
Temporal Trends and Evolving Outcomes After Simultaneous Liver-Kidney Transplantation: Results from the US SLKT Consortium. .
27:1613-1622.
2021
Subjective Cognition Reported by Caregivers Is Correlated With Objective Cognition in Liver Transplant Recipients. .
28:269-279.
2021
Inpatient Frailty Assessment Is Feasible and Predicts Nonhome Discharge and Mortality in Decompensated Cirrhosis. .
27:1711-1722.
2021
Renal Outcomes After Simultaneous Liver-Kidney Transplantation: Results from the US Multicenter Simultaneous Liver-Kidney Transplantation Consortium. .
27:1144-1153.
2021
Posttransplant Outcomes in Older Patients With Hepatocellular Carcinoma Are Driven by Non-Hepatocellular Carcinoma Factors. .
27:684-698.
2021
Implementing a Height-Based Rule for the Allocation of Pediatric Donor Livers to Adults: A Liver Simulated Allocation Model Study. .
27:1058-1060.
2021
Nonalcoholic Fatty Liver Disease and Diabetes Mellitus Are Associated With Post-Transjugular Intrahepatic Portosystemic Shunt Renal Dysfunction: An Advancing Liver Therapeutic Approaches Group Study. .
27:329-340.
2021
Histidine-Rich Glycoprotein Alleviates Liver Ischemia/Reperfusion Injury in Mice With Nonalcoholic Steatohepatitis. .
27:840-853.
2021
Variation in Racial Disparities in Liver Transplant Outcomes Across Transplant Centers in the United States. .
27:558-567.
2020
Outcomes of Liver Transplantation Among Older Recipients With Nonalcoholic Steatohepatitis in a Large Multicenter US Cohort: the Re-Evaluating Age Limits in Transplantation Consortium. .
26:1492-1503.
2020
In-Person Outreach and Telemedicine in Liver and Intestinal Transplant: A Survey of National Practices, Impact of Coronavirus Disease 2019, and Areas of Opportunity. .
26:1354-1358.
2020
Liver Transplant Survivorship. .
26:1030-1033.
2020
Physical Function, Physical Activity, and Quality of Life After Liver Transplantation. .
26:702-708.
2020
Chronic Kidney Disease in Liver Transplant Candidates: A Rising Burden Impacting Post-Liver Transplant Outcomes. .
26:498-506.
2020
Frailty Is Associated With Increased Rates of Acute Cellular Rejection Within 3 Months After Liver Transplantation. .
26:390-396.
2020
Differential Impact of Age Among Liver Transplant Candidates With and Without Hepatocellular Carcinoma. .
26:349-358.
2019
Physicians' Perspectives on Palliative Care for Patients With End-Stage Liver Disease: A National Survey Study. .
25:859-869.
2019
Split-Liver Allocation: An Underused Opportunity to Expand Access to Liver Transplantation. .
25:690-691.
2019
The Range and Reproducibility of the Liver Frailty Index. .
25:841-847.
2019
Impact of Chronic Kidney Disease on Outcomes in Cirrhosis. .
25:870-880.
2019
Outcomes After Listing for Liver Transplant in Patients With Acute-on-Chronic Liver Failure: The Multicenter North American Consortium for the Study of End-Stage Liver Disease Experience. .
25:571-579.
2019
Assessment of the spectrum of hepatic encephalopathy: A multicenter study. .
24:587-594.
2018
Transplant for the very sick: No limitations in donor quality? .
23:S40-S43.
2017
A multicenter study to define sarcopenia in patients with end-stage liver disease. .
23:625-633.
2017
Disability in patients with end-stage liver disease: Results from the functional assessment in liver transplantation study. .
23:292-298.
2017
Functional impairment in older liver transplantation candidates: From the functional assessment in liver transplantation study. .
21:1465-70.
2015
Outcomes for liver transplant candidates listed with low model for end-stage liver disease score. .
21:1403-9.
2015
Circulating levels of soluble receptor for advanced glycation end products and ligands of the receptor for advanced glycation end products in patients with acute liver failure. .
21:847-54.
2015
Decision support for organ offers in liver transplantation. .
21:784-91.
2015
Offer patterns of nationally placed livers by donation service area. .
19:404-10.
2013
Center competition and outcomes following liver transplantation. .
19:96-104.
2013
Recipient-donor race mismatch for African American liver transplant patients with chronic hepatitis C. .
18:524-31.
2012
Risk of advanced fibrosis with grafts from hepatitis C antibody-positive donors: a multicenter cohort study. .
18:532-8.
2012
Effects of ethnicity and socioeconomic status on survival and severity of fibrosis in liver transplant recipients with hepatitis C virus. .
18:461-7.
2012
Hepatic steatosis at 1 year is an additional predictor of subsequent fibrosis severity in liver transplant recipients with recurrent hepatitis C virus. .
17:1380-6.
2011
Gender disparity in liver transplant waiting-list mortality: the importance of kidney function. .
16:1147-57.
2010
Identity
International Standard Serial Number (ISSN)
